Brain Behavior and Immunity

Brain Behavior and Immunity is the official journal of the Psychoneuroimmunology Research Society, published by Elsevier since 1987 and covering interactions among the nervous, immune and endocrine systems and behaviour, with a 2025 Journal Impact Factor of 7.5 and a rank of 17th among 293 psychiatry journals《脑、行为与免疫》（Brain Behavior and Immunity）是（Psychoneuroimmunology Research Society）的官方期刊，1987 年由（Elsevier）创刊，覆盖神经、免疫、内分泌系统与行为的相互作用，2025 年影响因子为 7.5，在 293 种精神病学期刊中列第 17 位。

Scope

• Physiological mechanisms that carry messages between the immune and nervous systems and regulate their functions are the journal's central concern在免疫系统与神经系统之间传递信息并调控其功能的生理机制是该刊的核心关注。
• Stress and immunity are covered, including the action of stress-related hormones and neurotransmitters on immune cells应激与免疫被纳入，包括应激相关激素与神经递质对免疫细胞的作用。
• Cytokines, growth factors and microbial product activation of neurons and glia, and their effects on behaviour, learning, memory and neurogenesis, are core topics细胞因子、生长因子与微生物产物对神经元与胶质细胞的激活及其对行为、学习、记忆与神经发生的影响是核心主题。
• Immune-brain interactions in neurological, psychiatric and mental health disorders, and the role of immune processes in neurodegeneration, are included神经、精神与心理健康障碍中的免疫与脑相互作用，以及免疫过程在神经退行中的作用均被纳入。
• Neuroimaging of immune mechanisms, microglial involvement in pain and psychiatric disorders, and traumatic brain injury are part of the remit免疫机制的神经影像、小胶质细胞在疼痛与精神障碍中的作用以及创伤性脑损伤属于该刊范围。
• Sleep, exercise, nutrition, the microbiome, healthy ageing, perinatal inflammation and cancer treatment effects on brain and behaviour are covered睡眠、运动、营养、微生物组、健康衰老、围产期炎症与肿瘤治疗对脑与行为的影响均被覆盖。
• Translational work with a clinical or public health emphasis is redirected to the open access companion journal Brain Behavior and Immunity Health偏临床或公共卫生的转化研究被引导至开放获取姊妹刊（Brain Behavior and Immunity Health）。

History

• The journal was founded in 1987 and serves as the official publication of the Psychoneuroimmunology Research Society该刊于 1987 年创刊，是（Psychoneuroimmunology Research Society）的官方出版物。
• It is published by Elsevier under the Academic Press imprint, appearing eight times a year该刊由（Elsevier）以（Academic Press）名义出版，每年八期。
• Its impact factor moved from 7.217 in 2021 to 19.227 in 2022, then 7.6 in 2024 and 7.5 in 2025该刊影响因子由 2021 年的 7.217 升至 2022 年的 19.227，2024 年为 7.6，2025 年为 7.5。
• There are no submission fees or page charges, and manuscripts are typically peer reviewed and returned to authors within 30 days该刊不收取投稿费与版面费，稿件通常在同行的评审后 30 天内返还作者。
• Two companion titles extend the franchise, an open access health journal and an integrative journal for Asian mind-body research两个姊妹刊延伸了这一体系，其一为开放获取健康刊，其二为面向亚洲身心研究的整合刊。
• The journal is indexed in Science Citation Index Expanded, MEDLINE and Scopus, and publishes original research, reviews and commentary该刊被（Science Citation Index Expanded）、（MEDLINE）与（Scopus）收录，刊载原创研究、综述与评论。

Editors

• Carmine Pariante of King's College London is editor-in-chief and works on psychoneuroimmunology and the immune basis of depression主编（Carmine Pariante）任职于伦敦国王学院，研究心理神经免疫学与抑郁的免疫基础。
• Neil Harrison of Cardiff University and Sarah Spencer of RMIT University in Melbourne serve as deputy editors-in-chief（Neil Harrison）与（Sarah Spencer）任副主编，前者任职于卡迪夫大学，后者任职于墨尔本皇家理工大学。
• Fifteen associate editors cover Britain, Ireland, France, Sweden, Germany, Canada, the United States, Australia, Taiwan and mainland China15 位副编辑分布于英国、爱尔兰、法国、瑞典、德国、加拿大、美国、澳大利亚、台湾与中国大陆。
• Keith W. Kelley of the University of Illinois was editor-in-chief from 2003 to 2017 and is now editor-in-chief emeritus（Keith W. Kelley）于 2003 至 2017 年任主编，现为荣休主编，任职于伊利诺伊大学。
• The board exceeds 200 members across 23 countries, with 117 in the United States, 27 in Britain and 12 in China编委会超过 200 人，分布于 23 个国家，其中美国 117 人、英国 27 人、中国 12 人。
• The journal also appoints a social media editor, reflecting its effort to reach clinicians and trainees beyond the review process该刊另设社交媒体编辑，显示其在评审流程之外触达临床医生与受训者的努力。